News 2023-06-23
Porton Pharma Solutions Welcomes Alexandra Pichard Nielsen, VP of Business Development, at BOS Basel 2023, Driving Innovation and Growth in the Pharmaceutical Industry
We’re honored to have Alexandra Pichard Nielsen, Vice President for Business Development at Porton Pharma Solutions Ltd., join us at BOS Basel 2023!
We are excited to witness Alexandra’s expertise and leadership in action as she explores new opportunities, fosters partnerships, and drives business growth for Porton Pharma.
Stay tuned for insightful updates on how Alexandra is spearheading our company’s expansion and shaping the future of the pharmaceutical industry.
Drop by our booth at Stand 17 if you want to catch up with Alexandra!
If you would like to preschedule a meeting, https://lnkd.in/eFzuWJBN
Others
More
News 2025-04-16
Porton Advanced's End-to-End CDMO Solutions Accelerates IND Approval of Tasly's Innovative Dual-Targeting CAR-T Therapy
April 12, 2025 - Porton Advanced proudly announces its CDMO support for TASLY PHARMACEUTICAL CO., LTD’s Innovative Dual-Targeting CAR-T Therapy, "P134 Cell Injection," which has received Investigational New Drug (IND) approval from China's National Medical Products Administration (NMPA) (Approval No.: 2025LP01030). This breakthrough CAR-T therapy is indicated for recurrent glioblastoma (GBM).
News 2025-04-11
Porton Newsletter - March 2025 Recap
Technical Enabling Services & Solutions Company Events ESG Marketing Activities
